GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » G Medical Innovations Holdings Ltd (OTCPK:GMVDF) » Definitions » Days Sales Outstanding

G Medical Innovations Holdings (G Medical Innovations Holdings) Days Sales Outstanding : 48.16 (As of Dec. 2022)


View and export this data going back to 2017. Start your Free Trial

What is G Medical Innovations Holdings Days Sales Outstanding?

G Medical Innovations Holdings's average Accounts Receivable for the six months ended in Dec. 2022 was $0.58 Mil. G Medical Innovations Holdings's Revenue for the six months ended in Dec. 2022 was $2.20 Mil. Hence, G Medical Innovations Holdings's Days Sales Outstanding for the six months ended in Dec. 2022 was 48.16.

The historical rank and industry rank for G Medical Innovations Holdings's Days Sales Outstanding or its related term are showing as below:

GMVDF's Days Sales Outstanding is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 64.9
* Ranked among companies with meaningful Days Sales Outstanding only.

G Medical Innovations Holdings's Days Sales Outstanding declined from Dec. 2021 (52.84) to Dec. 2022 (48.16).


G Medical Innovations Holdings Days Sales Outstanding Historical Data

The historical data trend for G Medical Innovations Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G Medical Innovations Holdings Days Sales Outstanding Chart

G Medical Innovations Holdings Annual Data
Trend Sep16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Sales Outstanding
Get a 7-Day Free Trial 50.36 41.65 47.41 45.03 45.42

G Medical Innovations Holdings Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.63 43.33 52.84 44.02 48.16

Competitive Comparison of G Medical Innovations Holdings's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, G Medical Innovations Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G Medical Innovations Holdings's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where G Medical Innovations Holdings's Days Sales Outstanding falls into.



G Medical Innovations Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

G Medical Innovations Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (0.507 + 0.593) / 2 ) / 4.42*365
=0.55 / 4.42*365
=45.42

G Medical Innovations Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2022 is calculated as:

Days Sales Outstanding (Q: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2022 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (0.566 + 0.593) / 2 ) / 2.196*365 / 2
=0.5795 / 2.196*365 / 2
=48.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G Medical Innovations Holdings  (OTCPK:GMVDF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


G Medical Innovations Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of G Medical Innovations Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


G Medical Innovations Holdings (G Medical Innovations Holdings) Business Description

Traded in Other Exchanges
N/A
Address
5 Oppenheimer Street, Rehovot, ISR, 7670105
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
Executives
Awm Investment Company, Inc. 10 percent owner 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022

G Medical Innovations Holdings (G Medical Innovations Holdings) Headlines